Both cosmetic surgeons and clients were very pleased to find out when incobotulinumtoxin A, commonly known as Xeomin, was approved for cosmetic use by the FDA last July 2011 and is now back on the market. This wrinkle-filling product is joining the ranks of Botox and Dysport in temporarily reducing the appearance of moderate to severe frown lines, also known as the 11s, between the eyebrows. The Rejuvalife Vitality Institute is the most suitable venue for your Los Angeles Xeomin needs.
Newest Frown Fixer
Before its approval, Xeomin was previously used in adults as a treatment of cervical dystonia and blepharospasm. The former occurs when there are sudden contractions and spasms of the neck muscles while the latter refers to the involuntary flickering of the muscles surrounding the eyes. Like Botox, Xeomin works by blocking signal transmission from the nerves to the muscles.
Xeomin was approved by the FDA after numerous clinical trials involving 547 cases of healthy adult patients amongst 16 investigational sites. Currently, Xeomin the is the only type of botulinum toxin used in cosmetics which doesn’t require refrigeration. Apart from the U.S., Xeomin is also approved for use in Italy, Spain, Germany, France and the United Kingdom with BOCOUTURE® as its brand name.
Xeomin vs. Botox and Dysport
All three are approved by the FDA to reduce the appearance of wrinkles. Dosing with Xeomin is also similar to Botox. If you usually utilize 20 units of Botox, expect to receive 20 units of Xeomin as well.
On the other hand, what sets apart Xeomin from Botox and Dysport is how there are no additives incorporated to it. As a “naked” wrinkle-filler, there is less likelihood of hypersensitivity reaction from patients who are prone to produce antibodies of proteins and other components associated with Botox and Dysport.
The positive results of Xeomin will be noticeable within 3 to 7 days and could last between 3 to 6 months. Like Dysport and Botox, results will gradually improve over repeated injections.
Almost all cosmetic products have their own risks but the benefits of Xeomin often outweighs its risks, However, it still pays to know its associated risks. They are the following:
- Slight swelling or bruising on the injection site
- Swallowing and breathing problems in case the botulinum toxin is spread to other parts of the body
- In treating blepharospasm, common side effects of Xeomin include dry mouth, diarrhea, sagging, dry eyes, visual impairment and headache